
 
 
 
 
 
 
 
 
  What is Claimed is:  
   
 1. A method for attaching mammalian cell with a recombinant protein comprising one or more copies of the 2nd and/or the 4th fas-1 domain of .beta.ig-h3.  
 
     
 2. (deleted)  
 
     
 3. (deleted)  
 
     
 4. The method according to claim 1, wherein the 2nd fas-1 domain of .beta.ig-h3 comprises the amino acid sequence 237-377 of .beta.ig-h3.  
 
     
 5. The method according to claim 1, wherein the 4th fas-1 domain of .beta.ig-h3 comprises the amino acid sequence 498-637 of .beta.ig-h3.  
 
     
 6. The method according to claim 1, wherein the recombinant protein comprises the amino acid sequence 502-637 of .beta.ig-h3 in tetraplicate.  
 
     
 7. An expression vector p.beta.ig-h3 D-II, comprising amino acid sequence 237-377 of .beta.ig-h3 and capable of expressing the 2nd fas-1 domain of .beta.ig-h3.  
 
     
 8. An E. coli strain, transformed with the expression vector of claim 7, identified as E. coli BL21/His.beta.-g (accession No. KCTC 0905BP).  
 
     
 9. An expression vector p.beta.ig-h3 D-IV, comprising amino acid sequence 498-637 of .beta.ig-h3 and capable of expressing the 4th fas-1 domain of .beta.ig-h3.  
 
     
 10. An E. coli strain, transformed with the expression vector of claim 9, identified as E. coli BL21/His.beta.-e (accession No. KCTC 09048P).  
 
     
 11. An expression vector p.beta.ig-h3 D-IV 4X, expressing recombinant protein which comprises the amino acid sequence 502-637 of .beta.ig-h3 in tetraplicate.  
 
     
 12. An E. coli strain, transformed with the expression vector of claim 11, identified as E. coli BL21/His.beta.-e4x (accession No. KCTC 0906BP).  
 
     
 13. The method according to claim 1, comprising the steps of:   1) preparing a recombinant protein comprising one or more copies of the 2nd and/or the 4th fas-1 domain of .beta.ig-h3, by use of an expression vector;   2) coating the recombinant protein onto a solid support; and 3) applying cells to the protein-coated solid support.  
 
     
 14. A method for healing mammalian wound with a recombinant protein comprising one or more copies of the 2nd and/or the 4th fas-1 domain of .beta.ig-h3.  
 
     
 15. The method according to claim 14, comprising the steps of:   1) coating a solid support with a recombinant protein comprising one or more copies of the 2nd and/or the 4th fas-1 domain of .beta.ig-h3;   2) attaching cells to the solid support; and 3) applying the solid support to wounds.  
 
   
 
 
 
 
 
 
 
 
